Search is Powered by Google
Pharma Industry / Biotech Industry News

Bill 'Best Way To Ensure' Transparency Of Possible Conflicts Of Interest, Editorial States

Main Category: Pharma Industry / Biotech Industry
Also Included In: Medical Students / Training
Article Date: 11 Jun 2008 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

A report published last week that found three researchers from Harvard Medical School were "vastly underreporting their income from drug companies" offers "striking proof that today's requirements for reporting payments from industry -- essentially an honor system in which researchers are supposed to reveal their outside income to their institutions" -- must "be strengthened," a New York Times editorial states. According to the editorial, the results of the report -- published in the Congressional Record by Sen. Chuck Grassley (R-Iowa) -- are "particularly troublesome" because studies conducted by the three researchers have "helped fuel an explosion in the use of powerful antipsychotic drugs to treat children."

The editorial states, "Although supporters praise the most prominent of the trio" -- Joseph Biederman -- "as a visionary who has saved many lives, critics complain that the Harvard studies have been too small and loosely designed to provide conclusive results," adding, "Critics say they also were subject to biased interpretation through use of a subjective rating scale." The editorial states, "At this point, it is not clear whether the researchers inadvertently failed to comply with reporting rules or consciously sought to hide their sizable incomes from drug companies." However, "it is clear that relying on researchers to report their outside incomes and on universities and hospitals to police the disclosures won't suffice," according to the editorial.

A bill introduced by Grassley and Sen. Herb Kohl (D-Wis.) that would "require drug and device makers to report annually any payments to doctors that exceed $500 a year ... is the best way to ensure that conflicts of interest are transparent to all," the editorial concludes (New York Times, 6/10).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
U.S. FDA Approves Requip® XL™, The First And Only Oral Once-daily Non-ergot Dopamine Agonist For Parkinson's Disease
15 Jun 2008
GlaxoSmithKline announced the approval of Requip® XL™(ropinirole extended-release tablets) in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease...


Learning to Stretch the Right Way
Learning to Stretch the Right Way

Knowing the right way to stretch can prevent injury and help you make the most out of your workout.

more videos are available in our health videos section.